Atlas Capital Advisors LLC 10x Genomics, Inc. Transaction History

Atlas Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$19.45 - $37.37 $13,615 - $26,159	-700 Reduced 36.19%	1,234 $24 Million
Q4 2023 Feb 15, 2024	BUY	$34.32 - $57.55 $8,236 - $13,812	240 Added 14.17%	1,934 $108 Million
Q1 2023 May 16, 2023	BUY	$35.33 - $55.79 $5,864 - $9,261	166 Added 10.86%	1,694 $94.5 Million
Q4 2022 Feb 15, 2023	BUY	$24.4 - $41.3 $4,099 - $6,938	168 Added 12.35%	1,528 $55.7 Million
Q3 2022 Nov 08, 2022	BUY	$28.48 - $52.59 $12,104 - $22,350	425 Added 45.45%	1,360 $38.7 Million
Q2 2022 Aug 16, 2022	BUY	$36.95 - $82.41 $10,161 - $22,662	275 Added 41.67%	935 $42.3 Million
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $83,470 - $108,041	660 New	660 $93,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.